Fourth; the association of patient characteristics (age, weight, BMI, blood group, VWF level, factor VIII mutation, VWF:FVIII binding, VWF polymorphisms, current or past history of factor VIII inhibitor or inflammation) and PK parameters (AUC and half life) will be assessed using multivariate regression techniques.